The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 23, 2018

Filed:

Apr. 27, 2017
Applicant:

Samumed, Llc, San Diego, CA (US);

Inventors:

Sunil Kumar KC, San Diego, CA (US);

Chi Ching Mak, San Diego, CA (US);

Brian Walter Eastman, San Diego, CA (US);

Jianguo Cao, San Diego, CA (US);

Venkataiah Bollu, San Diego, CA (US);

Gopi Kumar Mittapalli, San Diego, CA (US);

Chandramouli Chiruta, San Diego, CA (US);

Assignee:

Samumed, LLC, San Diego, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4725 (2006.01); C07D 401/14 (2006.01); C07D 401/04 (2006.01); C07D 487/04 (2006.01); C07D 413/14 (2006.01); C07D 471/10 (2006.01); C07D 405/14 (2006.01); C07D 491/048 (2006.01); C07D 409/14 (2006.01); C07D 417/14 (2006.01); C07D 417/04 (2006.01); C07D 487/08 (2006.01);
U.S. Cl.
CPC ...
C07D 401/14 (2013.01); C07D 401/04 (2013.01); C07D 405/14 (2013.01); C07D 409/14 (2013.01); C07D 413/14 (2013.01); C07D 417/04 (2013.01); C07D 417/14 (2013.01); C07D 471/10 (2013.01); C07D 487/04 (2013.01); C07D 487/08 (2013.01); C07D 491/048 (2013.01);
Abstract

Isoquinoline compounds for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an isoquinoline compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, fibrotic disorders, bone or cartilage diseases, and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, as well as genetic diseases and neurological conditions/disorders/diseases due to mutations or dysregulation of the Wnt pathway and/or of one or more of Wnt signaling components. Also provided are methods for treating Wnt-related disease states.


Find Patent Forward Citations

Loading…